These studies provided the potential therapeutic candidate for CML, especially for those patients who developed into TKI resistant, and revealed the possible underlying molecular mechanism of coumarin derivative through caspase-3 mediated apoptosis. Here, CASP3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.